Combating AMR in Asia-Pacific: miniAST at the Center of FASAVA 2025
AMR Trends in the Asia-Pacific Region Antimicrobial resistance is becoming an increasing concern in companion-animal medicine across the Asia-Pacific, with veterinarians reporting more recurrent and difficult-to-treat infections. Recent studies have documented the rise of multidrug-resistant organisms such as ESBL-producing E. coli, MRSA, and MRSP in Thailand, Korea, and Malaysia, indicating a growing presence of resistant pathogens in dogs and cats (Satchasataporn et al., 2025; Seo et al., 2025; Afshar et al., 2023). A major contributor to this trend is the reliance on empirical antibiotic prescribing, driven by limited access to rapid diagnostic testing and low awareness of proper antibiotic use among pet owners. Research from Korea and Singapore shows that broad-spectrum antibiotics are often prescribed in the absence of timely AST results, reinforcing patterns that accelerate resistance (Kim et al., 2025). These challenges highlight the need for practical in-clinic tools that enable faster, evidence-based treatment decisions. Insights from Korean Veterinary Industry Leaders Mr. Kevin Ha, Vice President of PostBio Co., Ltd During the interview, Mr. Kevin Ha shared that antibiotic misuse is becoming increasingly serious in veterinary hospitals, similar to trends seen in human medicine. He explained that when antibiotic susceptibility testing is not performed, veterinarians often choose stronger antibiotics because they cannot confirm which drugs are effective. Antibiotic abuse is becoming more serious in the animal hospital market. When antibiotic testing is not done, strong antibiotics are often prescribed, and I believe this problem will continue to become more serious. Mr. Kevin Ha Vice President of PostBio Co., Ltd Upon being introduced to miniAST, he expressed strong optimism. He emphasized that traditional AST required 4–6 days, while miniAST provides results much more quickly. When I first saw miniAST, I thought, “This is the product I’ve been looking for.” It was impressive and hopeful. Previously, AST took at least 4-6 days, but with this product, the results come out very fast. It is extremely helpful, and we have high expectations. Mr. Kevin Ha Vice President of PostBio Co., Ltd Dr. Kyu Wook Kim, President of Solvet, Inc. Dr. Kim highlighted the growing global threat of antimicrobial resistance and referenced a widely cited projection. He stressed that antibiotics must be used carefully. As far as I know, by 2050, AMR is expected to cause more deaths than cancer. Antibiotics should be used properly and responsibly. They should not be used indiscriminately as they often are now. Dr. Kyu Wook Kim President of Solvet, Inc. When he first saw miniAST, he was surprised by its speed and practicality. I was very surprised. In the past, sending samples to a lab service took about 5–6 days including preparation, but miniAST provides results in about six hours. It is extremely efficient, and I believe equipment like this is absolutely necessary for the health of both humans and animals. Dr. Kyu Wook Kim President of Solvet, Inc. Dr. Kim also noted that the adoption of such devices in Korean clinics is steadily increasing, and broader use will help reduce unnecessary antibiotic prescriptions. If these devices become more widely used, we can reduce unnecessary antibiotic use and lower AMR-related risks. Dr. Kyu Wook Kim President of Solvet, Inc. Antimicrobial Resistance in the Republic of Korea Antimicrobial resistance (AMR) represents an important public health concern in Korea, where antibiotic consumption remains relatively high. According to the OECD, the daily defined doses of antibiotic prescriptions per 1,000 population in the Republic of Korea are among the highest reported across OECD member countries, indicating a potential risk for the development and spread of antimicrobial resistance (OECD, 2023; OECD, 2025). In response to AMR, the Republic of Korea established the First National Action Plan on Antimicrobial Resistance (2016–2020) based on the WHO Global Action Plan on AMR. This national strategy adopted a multi-sectoral approach encompassing human health, animal health, food safety, and environmental sectors. Within the animal health sector, key measures have included the strengthening of AMR surveillance systems and the introduction of antimicrobial stewardship program (ASP) pilot projects, aimed at promoting appropriate antimicrobial use and reducing antimicrobial resistance. The One Health AMR concept, which connects human, animal, and environmental health, has gained increasing attention across medical, veterinary, and environmental communities in the Republic of Korea. Korean veterinary medical societies have made significant efforts to minimize the potential impact of animal antimicrobial use on public and animal health. Studies and professional discussions indicate that many Korean veterinarians recognize the risks associated with the misuse or overuse of antibiotics and are considering the development of improved guidelines and regulatory measures. About the miniAST Veterinary AST Analyzer The Bioguard miniAST Veterinary Antibiotic Susceptibility Test Analyzer is an automated system designed specifically for veterinary antimicrobial susceptibility testing. It provides: Categorical susceptibility results (susceptible, intermediate, resistant) Automated interpretation to minimize human error Results within approximately six hours, enabling same day therapeutic adjustments Standardized, reproducible data to guide confident antibiotic selection By shortening the time between diagnosis and targeted therapy, miniAST helps veterinary clinics avoid unnecessary or ineffective antibiotic use, supporting responsible antimicrobial stewardship and improving clinical outcomes. References Afshar, M. F., Zakaria, Z., Cheng, C. H., & Ahmad, N. I. (2023). Prevalence and multidrug-resistant profiles of methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius in dogs, cats, and pet owners in Malaysia. Veterinary World, 16(3), 536–545. https://doi.org/10.14202/vetworld.2023.536-545 Kim, B., Kim, Y. J., & Lee, H. (2025). National action plan on antimicrobial resistance in the Republic of Korea: Progress and challenges. Infection & Chemotherapy, 57(1), 1–12. https://doi.org/10.3947/ic.2025.0028 Kim, S.-M., Kim, H.-S., Kim, J.-W., & Min, K.-D. (2025). Assessment of antimicrobial use for companion animals in the Republic of Korea: Developing defined daily doses and investigating veterinarians’ perception of antimicrobial resistance. Animals, 15(2), 260. https://doi.org/10.3390/ani15020260 Lee, J., Kim, D., & Choi, Y. (2025). Antimicrobial use and resistance in companion animals in Korea. Animals, 15(2), 260. https://www.mdpi.com/2076-2615/15/2/260 Organisation for Economic Co-operation and Development. (2023). Health at a glance 2023: OECD indicators. OECD Publishing. https://www.oecd.org/en/publications/health-at-a-glance-2023_8f9e3f98-en.html Organisation for Economic Co-operation and Development. (2025). Health at a glance 2025. OECD Publishing. https://www.oecd.org/en/publications/health-at-a-glance-2025_8f9e3f98-en.html Park, Y. H. (n.d.). One Health approach to
Bioguard Showcases miniAST at FASAVA 2025 in Daegu, Korea
From October 31 to November 2, 2025, Bioguard joined the 13th FASAVA Congress at EXCO in Daegu, Korea (R.O.K.), one of the key small animal veterinary events in the Asia-Pacific. Under the congress theme “One Vision, One Voice: Advancing Asia Pacific Veterinary Medicine” Bioguard showcased the miniAST Veterinary Antibiotic Susceptibility Test Analyzer as part of its commitment to smarter, evidence-based antimicrobial use in daily practice. Bringing miniAST to FASAVA 2025 At the Bioguard booth, veterinarians from across Asia and beyond were introduced to miniAST, a compact, clinic-friendly analyzer designed to make antibiotic susceptibility testing both faster and more accessible. Building on campaigns that highlighted miniAST’s speed and practicality, Bioguard demonstrated how the system can deliver susceptibility results in as little as 6 hours, with up to 92% accurate compared to traditional disc diffusion, while fitting easily into typical small-animal clinics. Expert Insights on miniAST Mr. Kevin Ha (Vice President of PostBio Co., Ltd) Mr. Kevin Ha shared that his first impression of miniAST was extremely positive, describing it as exactly the solution the market has been waiting for. He praised how the system dramatically shortens AST turnaround time, reducing the traditional 4–6 day workflow to just a few hours. He noted that this improvement makes miniAST highly practical and clinically impactful for veterinarians. Overall, he expressed strong optimism about its future adoption and usefulness in animal hospitals. Dr. Kyu Wook Kim, Ph.D. (President of Solvet, Inc) Dr. Kim expressed surprise and admiration when he first saw miniAST, highlighting its efficiency compared to conventional laboratory AST, which typically requires 5–6 days. He emphasized that miniAST provides reliable results in approximately 6 hours, offering a major improvement in diagnostic speed. He believes such in-clinic tools will greatly benefit veterinarians by simplifying workflows and enhancing treatment decision-making. Dr. Kim also noted that miniAST represents an essential advancement for modern veterinary practice. Looking ahead to FASAVA 2026 in Taipei As FASAVA 2025 came to a close in Daegu, excitement began building for FASAVA 2026 in Taipei, the next official host city and home of Bioguard. In 2026, Bioguard looks forward to welcoming regional and international veterinary experts and industry professionals to our home city, where we will further demonstrate how miniAST integrates into a comprehensive diagnostic portfolio supporting antimicrobial stewardship in daily practice. We remain committed to providing practical, evidence-based tools that help veterinarians make informed decisions and enhance patient care. Through its presence at FASAVA 2025, Bioguard underscored a clear message: antibiotic susceptibility testing is becoming more accessible than ever, and with innovations like miniAST, small-animal clinics can take a more proactive, data-driven approach to combating AMR. We look forward to meeting veterinarians, partners, and industry professionals in Taipei for FASAVA 2026, where Bioguard will continue advancing the future of veterinary diagnostics in the Asia-Pacific region. Future Commitment to Veterinary Experts By showcasing miniAST at the 13th FASAVA Congress at EXCO in Daegu, we strengthen our mission to elevate veterinary diagnostics and support veterinarians around the world. Our focus remains on delivering innovative solutions that help professionals offer better care and manage antibiotic resistance effectively. The miniAST Veterinary Antibiotic Susceptibility Test Analyzer, a tool designed to help combat antimicrobial resistance with game-changing features: Feature & Benefit Feature Benefit Fast Results Get results in just 6 hours, enabling swift and confident treatment. Automated Interpretations Instantly deliver precise susceptibility profiles, supporting faster, more informed clinical decisions and optimizing patient care. Dual-Sample Testing Double the efficiency with simultaneous analysis of two samples at once. High Accuracy Achieve an impressive 92% accuracy rate compared to traditional disc diffusion tests. 📌 Note for Veterinarians: The miniAST Veterinary Antibiotic Susceptibility Test Analyzer is available exclusively to licensed veterinarians and veterinary hospitals. 📩 How to Order miniAST To purchase miniAST or request a quotation, please contact our sales team or email our customer service: 📧 service@bioguardlabs.com ☎️ Please include your hospital name and contact number so our sales representative can follow up with you directly. https://fasava2025.org/
AMR Rise in Latin America: Insights from WSAVA 2025 and miniAST Solutions
The Growing AMR Challenge in Latin America Antimicrobial resistance (AMR) has emerged as one of the most critical health threats in both human and veterinary medicine. In the Latin American region, widespread antibiotic access, inconsistent treatment compliance, and limited diagnostic resources have accelerated resistance, complicating treatment options for everyday clinical cases. At the WSAVA Congress 2025 in Rio de Janeiro, Bioguard engaged with veterinary experts from Paraguay to explore how resistance is affecting regional clinical practice and how new diagnostic tools, the miniAST Veterinary Antibiotic Susceptibility Test Analyzer, can help veterinarians make evidence based treatment decisions faster. Insights from Paraguayan Veterinary Experts Dr. Carlos Cabrera, a veterinarian specializing in oncology and cytology, emphasized that antimicrobial resistance is already a major regional health concern, particularly the rapid rise of antibiotic resistance across clinical cases. Antibiotic resistance is becoming extremely important. Around 10 million people die each year due to antibiotic resistance, and in the next 15 to 20 years this number could rise to 39 million. Dr. Carlos Cabrera He explained that resistant infections increasingly complicate therapy in routine cases, underscoring the urgency of adopting faster diagnostic approaches. He emphasized the value of rapid antibiotic susceptibility testing: miniAST gives us a quick solution about which antibiotic to use, helping us avoid those that are resistant. It allows us to make treatment decisions based on evidence, not assumption. Dr. Carlos Cabrera Dr. Fabián Velázquez, a small animal veterinarian from San Lorenzo, Paraguay, described the real world challenges of AMR in clinical practice. When we perform an antibiogram culture, we see very high levels of resistance. Sometimes we hesitate because we don’t know which antibiotic will work, or we need to start combining drugs. It is extremely concerning. Dr. Fabián Velázquez He also highlighted the broad clinical utility of rapid AST: miniAST will help me every day in the clinic. It allows us to focus our diagnosis and treatment much better. Dr. Fabián Velázquez He emphasized the broad utility of rapid diagnostics across multiple clinical areas: I can use it in dentistry, dermatology, traumatic surgery, even cavity infections. It will help daily and in a very short time. Dr. Fabián Velázquez Both veterinarians agreed: rapid AST tools are not only convenient, they are becoming essential for accurate therapy, reduced empirical prescribing, and minimizing treatment failures. AMR in Latin America: The Regional Picture According to data from the Pan American Health Organization (PAHO), resistance rates among pathogens such as Escherichia coli, Staphylococcus aureus, and Klebsiella pneumoniae have been steadily increasing across Latin America. In veterinary medicine, this trend poses a direct threat to animal health, especially in regions with limited laboratory capacity and where empirical treatment remains common. Key factors driving AMR in Latin America include: Widespread availability of antibiotics without prescription Limited surveillance of regional bacterial resistance Delayed diagnostic confirmation in clinical cases Overlapping antibiotic use in both human and veterinary sectors This creates a dangerous feedback loop in which the lack of diagnostic testing leads to greater reliance on empirical therapy, driving increased resistance and ultimately resulting in more frequent treatment failures. Dr. Cabrera captured this concern clearly: When we treat animals without knowing the bacterial profile, we risk worsening resistance. It’s not just a veterinary issue, it’s a public health issue. Dr. Cabrera One Health Approach: miniAST as a Diagnostic Bridge The One Health initiative emphasizes the interdependence of human, animal, and environmental health. Veterinarians play a crucial role by ensuring antibiotics are used responsibly and only when supported by diagnostic evidence. By providing rapid, clinic based AST, miniAST bridges the diagnostic gap between clinical need and laboratory confirmation. It strengthens evidence based therapy, reduces unnecessary antibiotic exposure, and supports regional AMR surveillance efforts. Dr. Velázquez described the broader potential: If we could test every infection this way, we would reduce unnecessary antibiotic exposure. It would help veterinarians, owners, and even policymakers understand how to control resistance in our region. Dr. Velázquez About the miniAST Veterinary AST Analyzer The Bioguard miniAST Veterinary Antibiotic Susceptibility Test Analyzer is an automated system designed specifically for veterinary antimicrobial susceptibility testing. It provides: Categorical susceptibility results (susceptible, intermediate, resistant) Automated interpretation to minimize human error Results within approximately six hours, enabling same day therapeutic adjustments Standardized, reproducible data to guide confident antibiotic selection By shortening the time between diagnosis and targeted therapy, miniAST helps veterinary clinics avoid unnecessary or ineffective antibiotic use, supporting responsible antimicrobial stewardship and improving clinical outcomes. The miniAST Veterinary Antibiotic Susceptibility Test Analyzer, a tool designed to help combat antimicrobial resistance with game-changing features: Feature Benefit Fast Results Get results in just 6 hours, enabling swift and confident treatment. Automated Interpretations Instantly deliver precise susceptibility profiles, supporting faster, more informed clinical decisions and optimizing patient care. Dual-Sample Testing Double the efficiency with simultaneous analysis of two samples at once. High Accuracy Achieve an impressive 92% accuracy rate compared to traditional disc diffusion tests. 📌 Note for Veterinarians:The miniAST Veterinary Antibiotic Susceptibility Test Analyzer is available exclusively to licensed veterinarians and veterinary hospitals. 📩 How to Order miniASTTo purchase miniAST or request a quotation, please contact our sales team or email our customer service:📧 service@bioguardlabs.com☎️ Please include your hospital name and contact number so our sales representative can follow up with you directly. References Pan American Health Organization (PAHO). Antimicrobial Resistance in the Americas: Epidemiological Update 2021–2022. Washington, DC. World Health Organization (WHO). Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2022. Geneva: WHO. PAHO. One Health and Antimicrobial Resistance Technical Brief. 2022. Rodríguez-Medina N, et al. “Antimicrobial Resistance in Latin America: Current Status and Challenges.” Journal of Global Antimicrobial Resistance. 2021. López-Jiménez L, et al. “Antibiotic Use and Resistance in Latin America: A Systematic Review.” Infection Control & Hospital Epidemiology. 2020.
Bioguard Partners with Nu.Q® by Volition to Advance Canine Cancer Screening
Bioguard Reference Laboratory has long been recognized as a trusted leader in veterinary diagnostics. With ISO/IEC 17025 accreditation and BSL-2 laboratory certification, Bioguard proudly holds the distinction of being Taiwan’s first accredited animal disease testing laboratory. Equipped with advanced PCR technology and automated high-throughput systems, the laboratory delivers fast, precise, and reliable results to veterinarians. Supported by 24-hour client service, Bioguard remains dedicated to empowering veterinary professionals through innovative and dependable diagnostic solutions. Driven by a mission to elevate global diagnostic standards, Nu.Q® by Volition has established a partnership with Bioguard, recognizing the laboratory’s strong reputation, technical expertise, and proven reliability in veterinary diagnostics. This partnership reflects a shared vision: to make early cancer detection more accessible and precise for veterinarians worldwide. The collaboration between Bioguard and Nu.Q® by Volition grew naturally from shared values in advancing veterinary diagnostics and improving animal health. During their visit to Bioguard’s Reference Laboratory in Taiwan, Nu.Q® representatives observed the laboratory’s daily operations and commitment to quality. The visit provided an opportunity for open professional exchange, allowing both teams to discuss workflow practices, diagnostic standards, and the potential for integrating the Nu.Q® Vet Cancer Test into Bioguard’s existing services. Following the visit, the Nu.Q® team provided comprehensive technical training to Bioguard’s laboratory members, helping to ensure precise testing procedures and consistent interpretation of results. Through these discussions and hands-on sessions, both sides developed a deeper understanding of each other’s expertise and a shared sense of purpose in bringing reliable cancer screening tools to veterinarians. Nu.Q® can help veterinarians and owners understand a dog’s current physical condition and detect cancer at an early stage. If you are a dog owner who cares about your dog’s health, we encourage including the Nu.Q® Vet Cancer Test as part of your pet’s annual wellness exam. Through Bioguard’s Reference Laboratory, veterinarians can now access this testing service to support early cancer screening. This allows both pet owners and veterinarians to gain a clearer, more comprehensive understanding of a dog’s overall health. Dr. Peggy Lan DVM Technical Support Specialist, Bioguard Corporation The collaboration began when Nu.Q® by Volition recognized Bioguard’s strong reputation, technical expertise, and laboratory capabilities, making it an ideal partner to implement their advanced canine cancer test in Taiwan. Through professional discussions, training sessions, and shared values in advancing veterinary medicine, both teams identified a shared goal: to combine global innovation with local expertise. About Nu.Q® by Volition The Nu.Q® Vet Cancer Test is a cutting-edge, non-invasive blood test for dogs that detects circulating nucleosomes, DNA-protein fragments released into the bloodstream during cancer and cell death. Designed as an early cancer screening and monitoring tool, it is particularly recommended for senior dogs (over seven years old) and breeds predisposed to cancer. 🧑⚕️ Nu.Q® Vet Cancer Test – Veterinarians – Volition Explore our comprehensive diagnostic testing services tailored for veterinary professionals. At Bioguard, we conduct advanced molecular diagnostics, endocrinology, hematology/chemistry, genetic testing, allergen screening, bacteriology, and histopathology/cytology in one centralized laboratory. Visit our Diagnostic Testing Services to discover how we support precise and evidence-based diagnoses for veterinarians. 🔗https://www.bioguardlabs.com/diagnostic-testing-services/
Bioguard Launches miniAST at WSAVA Congress 2025 in Rio de Janeiro, Brazil
Showcasing Bioguard Veterinary Diagnostics Products From September 25–27, 2025, at the WSAVA Congress in Rio de Janeiro, Brazil, Bioguard proudly presented the miniAST Veterinary Antibiotic Susceptibility Test Analyzer. miniAST provides rapid, precise antibiotic susceptibility testing, helping veterinarians make informed treatment decisions while supporting the global fight against antimicrobial resistance (AMR). Engaging with Veterinary Professionals During WSAVA Congress 2025 in Rio, Bioguard’s booth welcomed veterinary professionals from around the world, all eager to experience miniAST firsthand. Through live demonstrations, visitors could see the device’s speed, accuracy, and ease of use in action. Attendees asked questions, explored practical applications, and discovered how miniAST can make diagnostics more efficient and reliable in everyday clinical practice. Among the experts who visited the booth were: Dr. Ernesto Bruzzone from the Instituto Gastroenterológico Veterinario, Argentina. He is a leading veterinarian and founder of the Institute of Veterinary Gastroenterology, which for 27 years has educated professionals across Latin America through congresses, diploma programs, and internships. He earned his Veterinary Medicine degree at the National University of La Plata and later specialized in Endoluminal Endoscopy and Minimally Invasive Surgery in Spain. In addition, he teaches postgraduate courses and frequently speaks at national and international conferences. We also had the opportunity to interview veterinarians, including professionals from Paraguay, gaining valuable insights from their experiences and perspectives on advancing veterinary care in the region. Dr. Fabian Velazquez Dr. Fabián Velázquez, a 2016 graduate of the National University of Asunción, is a veterinarian committed to excellence in animal care, with specializations in University Teaching, Veterinary Ultrasound, and Small Animal Clinical Laboratory work. He sees animals as cherished family members, providing compassionate, personalized care and long-term well-being for each patient. Beyond the clinic, he is active in his community as a board member of the Asociación Joven Rural del Paraguay and serves as Paraguay’s Ambassador for FORVET, while also participating in K9 search dog training programs. http://agroclinicacapital.agenciawebporta.com/ These interactions offered valuable insights into clinical challenges and the practical applications of miniAST in veterinary practice. Dr. Carlos Cabrera Dr. Carlos Cabrera is a veterinarian who graduated in 2019 from the National University of Asunción. Passionate about veterinary oncology and cytology, he holds a certification in oncology and dedicates his career to the comprehensive care of pets. He firmly believes that our animals are part of the family and that, even when a cure is not possible, it is always possible to care for them with love, respect, and commitment. Driving Responsible Antibiotic Use miniAST allows veterinarians to quickly identify the most effective antibiotics, helping reduce unnecessary or ineffective treatments. This not only leads to better outcomes for patients but also supports responsible antimicrobial stewardship, an important step in the global fight against antimicrobial resistance (AMR). Future Commitment to Veterinary Experts By showcasing miniAST at WSAVA Congress, we reinforce our dedication to advancing veterinary diagnostics and supporting veterinarians worldwide. We remain committed to providing innovative solutions that enable professionals to deliver high-quality care while addressing the challenges of antimicrobial resistance. The miniAST Veterinary Antibiotic Susceptibility Test Analyzer, a tool designed to help combat antimicrobial resistance with game-changing features: Feature Benefit Fast Results Get results in just 6 hours, enabling swift and confident treatment. Automated Interpretations Instantly deliver precise susceptibility profiles, supporting faster, more informed clinical decisions and optimizing patient care. Dual-Sample Testing Double the efficiency with simultaneous analysis of two samples at once. High Accuracy Achieve an impressive 92% accuracy rate compared to traditional disc diffusion tests. 📌 Note for Veterinarians: The miniAST Veterinary Antibiotic Susceptibility Test Analyzer is available exclusively to licensed veterinarians and veterinary hospitals. 📩 How to Order miniAST To purchase miniAST or request a quotation, please contact our sales team or email our customer service: 📧 service@bioguardlabs.com ☎️ Please include your hospital name and contact number so our sales representative can follow up with you directly. https://wsava-congres13/
Bioguard x 92nd PVMA : Advancing Veterinary Diagnostics
The 92nd PVMA Scientific Conference and Annual Convention has been an incredible experience filled with “learning, innovation, and collaboration”. As we wrap up Day 1 & 2, Bioguard is proud to have played a part in this event in philippine, bringing comprehensive veterinary diagnostic solutions to phillippine veterinary field. Showcasing Bioguard Veterinary Diagnostics Products At 92nd PVMA, Bioguard introduced two of our advanced diagnostic equipment: Qmini Real-Time PCR Analyzer – A rapid and precise in-clinic PCR test that enhances veterinary disease detection. miniCHEM Biochemical & Coagulation Analyzer –A bifunction biochemistry analyzer to deliver #reliable #results, and all it needs is #MicroVolume of #blood sample for each #test. Veterinarians and industry professionals had the opportunity to explore our comprehensive solutions and discussions about their potential impact on the veterinary healthcare field. We appreciate the overwhelming interest expressed by attendees. Engaging with Veterinary Experts Beyond showcasing our products, PVMA 2025 allowed us to connect with leading professionals in the veterinary field. Among them were: Dr. Joel Tolentino – A professional veterinarian, also our speaker for bioguard online webinars, Canine Vector Borne Diseases- Diagnosis in the Companion Animal Practice Dr. Paul – The first veterinarian in the Philippines to install the Qmini Real-Time PCR Analyzer. Dr. Paul is going to lead a workshop with Maveson next month, further educating veterinarians on advanced diagnostic techniques. These interactions reinforce our commitment to supporting veterinarians with the latest diagnostic advancements, ensuring better pet healthcare. Future Commitment to Veterinary Experts Bioguard remains dedicated to delivering high-quality, innovative veterinary diagnostic solutions that empower veterinarians worldwide. We extend our heartfelt gratitude to all who visited our booth, engaged in discussions, and contributed to the success of PVMA 2025. For further information about our diagnostic solutions, feel free to contact us: 📩 Email: service@bioguard.com.tw PVMA webisite: https://www.facebook.com/profile.php?id=100064780414291 We look forward to seeing you again at future veterinary conferences!
Bioguard’s Cutting-Edge Technology Gains International Recognition in Dierenartsen Wereld Magazine
Bioguard is dedicated to innovation in animal health, providing efficient and precise diagnostic solutions for veterinarians and animal care professionals worldwide. We are honored to be featured in the renowned European veterinary magazine, Dierenartsen Wereld, where we share insights with international veterinary experts on the latest advancements in clinical diagnostics and contribute to the development of veterinary medicine. Dierenartsen Wereld is one of the most influential veterinary publications in Europe, focusing on clinical research, diagnostic technologies, and industry trends to provide authoritative information for veterinarians globally. Our publication not only highlights Bioguard’s expertise in veterinary diagnostics but also strengthens our collaboration and knowledge exchange with international experts. Accurate diagnostics are crucial for clinical decision-making. At Bioguard, we continuously strive to enhance diagnostic efficiency, reduce testing time, and help veterinarians respond swiftly to clinical challenges. Our advanced technology improves diagnostic accuracy while minimizing unnecessary treatments, ensuring a more scientific approach to animal healthcare. Bioguard remains committed to advancing veterinary medicine through innovation, providing global veterinary professionals with effective clinical support. We invite you to read the December issue of Dierenartsen Wereld and stay updated on the latest developments in veterinary science. 📖 For more information, visit Dierenartsen Wereld 🔗 https://dierenartsenwereld.be/
Vietnam seminar
On December 17, 2024, Bioguard, in collaboration with our Vietnam partner, successfully hosted the seminar “Comprehensive Approach and Diagnostic Strategies for Blood Parasites in Small Animals.” The event was met with participation, attracting numerous Vietnamese veterinarians and professionals from the pet healthcare sector to explore the latest advancements and clinical applications in blood parasite diagnostics. Bioguard is committed to providing veterinarians with high-quality diagnostic solutions. This seminar was not only a platform for sharing professional knowledge but also an important opportunity to foster international collaboration. We were deeply inspired by the professionalism and eagerness to learn demonstrated by our Vietnamese colleagues, further strengthening our resolve to advance the development of global veterinary diagnostics. The success of this seminar would not have been possible without the full support of our partner team. Their exceptional venue and assistance allowed us to engage in meaningful exchanges with Vietnam’s veterinary professionals. Moving forward, we will continue to collaborate closely with our partner in Vietnam and other international partners. Bioguard extends our heartfelt gratitude to everyone who participated in this seminar! We look forward to meeting you again at future international events. 👉 Stay tuned to Bioguard’s official website and social media platforms for more company updates and upcoming events! https://youtube.com/embed/AJ_PFiMU4Z0
Bioguard Expertise Featured in Buddy Life Magazine
As a leader in veterinary science, Bioguard is committed to delivering cutting-edge knowledge to pet owners and professionals. We’ve collaborated multiple times with India’s premier canine publication, 《Buddy Life Magazine》, to provide practical advice and insights. Recently, our team contributed a feature article to 《Buddy Life Magazine》, highlighting the prevention of Infectious Canine Hepatitis (ICH) and its significance in protecting puppy health. The article offers expert knowledge on reducing infection risks and safeguarding canine well-being. Discover more professional insights: 🐾 https://www.buddylifemagazine.com/
Celebrating Taiwan Veterinarian Day in Bioguard
Every year on January 6th, we honor the dedicated Taiwan veterinary field professionals with Taiwan Veterinarian Day. At Bioguard, we sincerely appreciate all veterinarians for their continuous contributions to animal health. You are the key to ensuring the happiness and well-being of our furry companions! ✨ This year, we are honor to invite our veterinarian friends to visit Bioguard office and laboratory. Together, let’s witness our advancements in technology and innovation in services. This event is not only an opportunity to showcase our new facilities but also to foster meaningful exchanges. We look forward to hearing your valuable professional insights and building a stronger foundation for future collaborations. ✨ Our Commitment We will continue to enhance the quality of our products and provide more precise tools and services to support veterinarians in achieving greater diagnostic accuracy. Thank you for your dedication and perseverance. Because of you, our beloved animals can grow up healthy and happy! Let’s join hands to create a new milestone in animal health together!